Portfolio record
Luang Pharma is establishing a pharmaceutical manufacturing facility in the Boten Economic Zone, Lao PDR. The portfolio below is being prepared for submission and registration; it is not an offer of supply and no line is registered or available yet.
About Chlorhexidine
Chlorhexidine is a synthetic cationic bisbiguanide compound with broad-spectrum biocidal properties. Its mechanism of action involves binding to negatively charged microbial cell walls, causing membrane disruption, leakage of intracellular components, and precipitation of the cytoplasm at higher concentrations. Introduced in the 1950s, the substance is featured on the WHO Model List of Essential Medicines and is extensively detailed in global pharmacopoeias. Internationally, the compound is prepared as aqueous or alcoholic solutions, surgical scrubs, oral mouthwashes, and medicated dressings.
This text describes the substance in general terms using publicly available pharmacological references. It is not labelling for any Luang Pharma product, and no Luang Pharma product containing this substance is registered or available for supply.
Brand name
Brand name: to be confirmed on registration. The line is identified here by its international non-proprietary name.
Dosage form
Aqueous or alcoholic solutions present the bisbiguanide in a liquid format designed for direct topical application, surface disinfection, or dilution prior to dermal use.
Regulatory position
Before this line can be supplied: Lao FDD registration, GMP batch records, validated method, stability program, QA release and approved trilingual labeling required.
This page states the product identity only. It carries no information about medical use, and it is not a substitute for approved labelling or the judgement of a qualified healthcare professional.
Requesting documentation
Regulatory, technical and distribution enquiries are answered at info@luangpharma.com. Please state the country, your company, the portfolio reference above and the documentation you need.
